A nasal swab containing a test sample is mixed with a simple lab test. It contains a liquid mixed with gold nanoparticles attached to a molecule that binds to the novel coronavirus. If the virus is present, the gold nanoparticles turns the solution a deep blue color (bottom of the tube) and a precipitation is noticed. If it is not present, the solution retains its original purple color.
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present. The test does not require the use of any advanced laboratory techniques, such as those commonly used to amplify DNA, for analysis. The authors published their work last week in the American Chemical Society’s nanotechnology journal ACS Nano.
“Based on our preliminary results, we believe this promising new test may detect RNA material from the virus as early as the first day of infection. Additional studies are needed, however, to confirm whether this is indeed the case,” said study leader Dipanjan Pan, PhD, Professor of Diagnostic Radiology and Nuclear Medicine and Pediatrics at the UMSOM.
Once a nasal swab or saliva sample is obtained from a patient, the RNA is extracted from the sample via a simple process that takes about 10 minutes. The test uses a highly specific molecule attached to the gold nanoparticles to detect a particular protein. This protein is part of the genetic sequence that is unique to the novel coronavirus. When the biosensor binds to the virus’s gene sequence, the gold nanoparticles respond by turning the liquid reagent from purple to blue.
“The accuracy of any COVID-19 test is based on being able to reliably detect any virus. This means it does not give a false negative result if the virus actually is present, nor a false positive result if the virus is not present,” said Dr. Pan. “Many of the diagnostic tests currently on the market cannot detect the virus until several days after infection. For this reason, they have a significant rate of false negative results.”
Dr. Pan created a company called VitruVian Bio to develop the test for commercial application. He plans to have a pre-submission meeting with the U.S. Food and Drug Administration (FDA) within the next month to discuss requirements for getting an emergency use authorization for the test. New FDA policy allows for the marketing of COVID-19 tests without requiring them to go through the usual approval or clearance process. These tests do, however, need to meet certain validation testing requirements to ensure that they provide reliable results.
“This RNA-based test appears to be very promising in terms of detecting the virus. The innovative approach provides results without the need for a sophisticated laboratory facility,” said study co-author Matthew Frieman, PhD, Associate Professor of Microbiology and Immunology at UMSOM.
Although more clinical studies are warranted, this test could be far less expensive to produce and process than a standard COVID-19 lab test; it does not require laboratory equipment or trained personnel to run the test and analyze the results. If this new test meets FDA expectations, it could potentially be used in daycare centers, nursing homes, college campuses, and work places as a surveillance technique to monitor any resurgence of infections.
In Dr. Pan’s laboratory, research scientist Parikshit Moitra, PhD, and UMSOM research fellow Maha Alafeef conducted the studies along with research fellow Ketan Dighe from UMBC.
Dr. Pan holds a joint appointment with the College of Engineering at the University of Maryland Baltimore County and is also a faculty member of the Center for Blood Oxygen Transport and Hemostasis (CBOTH).
“This is another example of how our faculty is driving innovation to fulfill a vital need to expand the capacity of COVID-19 testing,” said Dean E. Albert Reece, MD, PhD, MBA, who is also Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor, University of Maryland School of Medicine. “Our nation will be relying on inexpensive, rapid tests that can be dispersed widely and used often until we have effective vaccines against this pandemic.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Covid-19 cases hit 23,301 in Khulna, 22,039 recoverson November 12, 2020 at 4:00 pm
With detection of 36 new positive cases in all ten districts of the division, the total number of COVID-19 infected patients now hit 23,301 till Thursday noon. A total of 23,301 have been cured from ...
- UNICEF Global COVID-19 Situation Report No. 14: October 2020on November 12, 2020 at 3:24 pm
English Situation Report on World and 12 other countries about Contributions, Coordination, Epidemic and more; published on 12 Nov 2020 by UNICEF ...
- Biotech Involved in COVID-19, Neurodegenerative Diseases Reports Q3/20 Resultson November 12, 2020 at 3:13 pm
(PMN:TSX; ARFXF:OTCQB) announced in a news release its operational and financial results for Q3/20. During the three months ended Sept. 30, 2020, "the value of our unique discovery and development ...
- Halberd Corporation Reveals Patent-Pending Fluorescent Antibody's Wide Role in Covid-19 Detection & Treatmenton November 12, 2020 at 1:15 pm
JACKSON CENTER, PA / ACCESSWIRE / November 12, 2020 / Halberd Corporation (OTC PINK: HALB) today disclosed information on their patent-pending fluorescent anti-Spike protein monoclonal antibodies ...
- Rapid COVID-19 detection test in Sri Lanka soonon November 11, 2020 at 7:33 pm
The country is due to receive 100,000 antigen test kits for expedited COVID 19 detection next week from the World Health Organisation (WHO), Pharmaceutical Production and Regulation State Minister ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Visual detection of Covid-19
- South Africa: Early Warning As a Crisis Management Fundamental - Applicability to the Managing of the Covid-19 Pandemic Funds in South Africaon November 11, 2020 at 8:14 am
The managing of any crisis tends to be defined by the extent to which suitable measures are available and implemented to address the potential impact of any such eventuality. Adjoined to the process ...
- The Power Behind The Apple iPhone 12 Pro’s Coolest Feature Could Be Coming To The Macon November 10, 2020 at 9:41 am
The new iPhone 12 Pro have a new feature called People Detection which is timely and useful. And for the first time, the processor in the predicted new Macs will be near-identical to that in the ...
- LiDAR Market 2020 Global Trends, Key Company Profiles, Share, Growth, Analysis, Opportunities and Forecast To 2026on November 10, 2020 at 4:26 am
The globalLiDARmarket size is projected to reach USD 6.71 billion by 2026. Driven by increasing investments in ...
- Sniffing out the virus: Dogs in France can be retrained in weeks to detect COVID-19on November 9, 2020 at 8:23 am
Scientists in France are exploring an idea already being used in Finland; using dogs to sniff out COVID-19. They say dogs could be brought into action within weeks if the government gives the go-ahead ...
- Tata Medical launches Feluda covid-19 test under brand ‘Check’on November 8, 2020 at 11:55 pm
The TataMD Check test kits will be manufactured at the company’s facility near Chennai, which currently has a capacity of producing 1 million kits in a month ...